1Li TC, Chart MC, Lee N. Clinical implication of antiviral resistance in influenza[J]. Virus, 2015,7(9) : 4929-4944.
2Faqi AS, Klug A, Merker HJ, et al. Ganciclovir induces reproductive hazards in male rats after short-term exposure[ J ]. Hum Exp Toxicol, 1997, 16(9) : 505-511.
3Nihi F, Moreira D, Santos Lourenqo AC,et al. Testicular effects fol- lowing in utero exposure to the antivirals acyclovir and ganciclovir in rats[J]. Toxicol Sci, 2014, 139(1): 220-233.
4国家食品药品监督管理局药品审评中心.药物生殖毒性研究技术指导原则[S].2006.
5US Food and Drug Administration. Guidance for industry: Reproduc- tive and developmental toxicities-Integrating study results to assess con- cerns [ EB/OL ]. www. fda. gov/downloads/Drugs/GuidanceCompli- Guidanees/ucm079240. pdf. 2011-09/2015- 12-28.
6US Food and Drug Administration. Guidance for industry: Pregnancy, Lactation, and Reproductive Potemial: Labeling for Human Prescrip- tion Drug and Biological Products-Content and Format. Draft guidance. [ EB/OL]. http ://www. fda. gov/downloads/Drugs/GuidanceCompli- anceRegulatorylnformation/Guidances/ucm425398, pdf. 2014-12/2015- 12-28.
7De Clercq E, Leyten R, Sobis H, et al. Inhibitory effect of a broad- spectrum antiviral agent, ( S ) -9-( 2,3-dihydroxypropyl ) adenine, on spermatogenesis in mice [ J ]. Toxicol Appl Pharmacol, 1981,59 ( 3 ) : 441-451.
8Movahed E, Nejati V, Sadrkhanlou R, et al. Toxic effect of acyelovir on testieular tissue in rats[J]. Iran J Reprod Med, 2013, 11(2) : 111-118.
